PBI-4419

N/A

Report date: 2023/11/17 09:30:10
NME

Base Information

Drug NamePBI-4419
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionConnective tissue growth factor inhibitors
TargetsConnective tissue growth factor
Therapy Area/IndicationsInflammationFibrosisAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPrometic Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiminal BiosciencesShanghai Allist Pharmaceutical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationFibrosisAcute Kidney Injury

Other Information

ATC CodeN/A
Related LinksN/A